Approval · Notice of Compliance 1525 · 2000
ANDRODERM: Notice of Compliance 1525
Issued November 29, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1525
- Date
- November 29, 2000
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Testosterone replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDRODERM | 02239653 | Cancelled Post Market |
Medicinal ingredients
- TESTOSTERONE 12.2 MG per PAD